Genomic differences selected through evolution may offer clues as to why COVID-19 outcomes vary widely

A team from the University of Pennsylvania analyzed genomic data from global populations, including thousands of ethnically diverse Africans, to identify genetic variants that may be associated with clinical COVID-19 outcomes.

Molecular mechanism of interaction between SARS-CoV-2 and host cells and interventional therapy

Perspectives on SARS-CoV-2 strains

Frontiers SARS-CoV-2: Structure, Biology, and Structure-Based Therapeutics Development

Perelman School of Medicine

Telehealth and Mobile Health: Case Study for Understanding and

COVID-19: what has been learned and to be learned about the novel coronavirus disease

Genomics Penn Today

About COVAX

A molnupiravir-associated mutational signature in global SARS-CoV-2 genomes

June 2022 University of Pennsylvania

Frontiers Molecular and Clinical Investigation of COVID-19: From Pathogenesis and Immune Responses to Novel Diagnosis and Treatment

Research Penn Today

Dozens of Genomic Variations May Drive COVID-19 Clinical Outcomes